Ipilimumab is a monoclonal antibody used in cancer immunotherapy to stimulate the immune system to attack tumors. It targets CTLA-4 to release immune checkpoints, enhancing T-cell responses. As a complex biologic, its name is derived from Latinized chemical naming conventions rather than everyday language.
Full pronunciation guide
